REFERENCES
- Adam K, Oswald I. Protein synthesis, bodily renewal and the sleep-wake cycle. Clin Sci. 1983; 65: 561–67
- Barni S, Lissoni P, Cazzaaniga M, et al. A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates. Oncology 1995; 52: 243–45
- Bradley C M, Nicholson A N, Viveash J P. Opioids and non opioids. Ambulatory anesthesia and sedation: impairment and recovery, I D Klepper, L D Saunders, M Rosen. Blackwell Scientific, OxfordEngland 1991; 218–34
- Burns A M, Shelly M P, Park J R. The use of sedative drugs in critically ill patients. Drugs 1992; 43: 507–15
- Cajochen C, Krauchi K, Mori D, et al. Melatonin and S-20098 increase REM sleep and wake up propensity without modifying NREM sleep homeostasis. Am J Physiol 1997; 272(4 pt 2)1189–96
- Cole R J, Kripke D F, Gruen W, et al. Automatic sleep/wake identification from wrist activity. Sleep 1992; 15: 461–69
- Conti A, Maestroni G J. Melatonin rhythms in mice: role in autoimmune and lymphoproliferative diseases. J Pineal Res 1996; 20: 164–72
- Easton C, Mackenzie F. Sensory-perceptual alterations: delirium in the intensive care unit. Heart Lung 1988; 17: 229–37
- Folkard A, Arendt J. Can melatonin improve shiftworker tolerance to the night shift? Some preliminary findings. Chronobiol Int 1993; 1: 315–20
- Garfinkel D, Laudon M, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995; 346: 541–44
- Gonzales R, Sanchez A, Ferguson J A, et al. Melatonin therapy of advanced human malignant melanoma. Melanoma Res 1991; 1(4)237–43
- Helton M C, Gordon S H, Nunnery S L. The correlation between sleep deprivation and the intensive care unit syndrome. Heart Lung 1980; 9: 464–68
- Krachman S L, D'Alonzo G E, Criner J G. Sleep in the intensive care unit. Chest 1995; 107: 1713–20
- Lewis K S, McCarthy R J, Rothenberg D M. Does melatonin decrease sedative use and time to extubation in patients requiring prolonged mechanical ventilation. Anesth Analg 1999; 88: S123
- Maestroni G J. Melatonin as a therapeutic agent in experimental endotoxic shock. J Pineal Res 1996; 20: 84–91
- Myers T J, Eveloff S E, Bauer M S, et al. Adverse environmental conditions in the respiratory and medical ICU setting. Chest 1994; 105: 1211–16
- Palmblad J, Cantell K, Strander H, et al. Stressor exposure and immunological response in man: interferon-producing capacity and phagocytosis. Psychosom Res 1976; 20: 193–99
- Petrie K, Dawson A G, Thompson L, et al. A double blind trial of melatonin in international cabin crew. Biol Psychiatry 1993; 33: 526–30
- Pierapoli W, Regelston W. Pineal control of aging: effects of melatonin and pineal grafting on aging mice. Proc Natl Acad Sci. 1994; 91: 87–91
- Rechtschaffen A, Gilliland M A, Bergman B M, et al. Physiological correlates of prolonged sleep deprivation in rats. Science 1982; 221: 182–84
- Shilo L, Dagan Y, Smorjik Y, et al. Patients in the intensive care unit suffer from severe lack of sleep associated with loss of normal melatonin secretion pattern. Am J Med Sci., In press 1999
- Treggiari-Venzi M, Borgeat A, Fuchs-Buder T, et al. Overnight sedation with midazolam or propofol in the ICU: effects on sleep quality, anxiety and depression. Intensive Care Med 1996; 22: 1186–90
- Webb S M, Puig-Domingo M. Role of melatonin in health and disease. Clin Endocrinol 1995; 42: 221–34